BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Information Letter on Pegasys® (pegylated interferon alfa 2a) pre-filled syringes: Possible shortage

Active substance: pegylated interferon alfa 2a

Possible shortage of the pharmaceutical form Pegasys® pre-filled syringes and recommendations for healthcare professionals. Prefilled pens are not affected.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 800KB, File is accessible